Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.02 USD | -6.50% | +0.33% | -22.16% |
04-18 | Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board | CI |
03-12 | Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.16% | 96.34M | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- ANIX Stock
- News Anixa Biosciences, Inc.
- Anixa Biosciences Says New COVID-19 Compound Shows Promise in Preliminary Lab Test